<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">A total of 10
 <sup>7</sup> TCID
 <sub>50</sub> of influenza challenge virus was delivered intranasally as previously described
 <sup>
  <xref ref-type="bibr" rid="CR22">22</xref>
 </sup>. All participants were required to remain in isolation for approximately 10 days. Participants were discharged on day 7 post-challenge if they were afebrile, were clinically and hemodynamically stable, and had two negative diagnostic tests for influenza on consecutive days. Participants attended follow-up visits on days 35 and 63.
</p>
